Drug Discovery Stocks List

Recent Signals

Date Stock Signal Type
2020-01-17 ABVC Gilligan's Island Buy Setup Bullish Swing Setup
2020-01-17 ABVC Narrow Range Bar Range Contraction
2020-01-17 ABVC Lower Bollinger Band Walk Weakness
2020-01-17 AMBS Crossed Above 20 DMA Bullish
2020-01-17 AMBS Expansion Pivot Buy Setup Bullish Swing Setup
2020-01-17 AMBS Crossed Above 50 DMA Bullish
2020-01-17 AMBS 180 Bullish Setup Bullish Swing Setup
2020-01-17 ATHJF Narrow Range Bar Range Contraction
2020-01-17 ATHJF Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2020-01-17 ATHJF Stochastic Reached Oversold Weakness
2020-01-17 AURX Fell Below 20 DMA Bearish
2020-01-17 AURX Narrow Range Bar Range Contraction
2020-01-17 AURX Stochastic Sell Signal Bearish
2020-01-17 BNOEF Narrow Range Bar Range Contraction
2020-01-17 DTRK 20 DMA Support Bullish
2020-01-17 DTRK Crossed Above 50 DMA Bullish
2020-01-17 EVTCY Narrow Range Bar Range Contraction
2020-01-17 LGNDZ Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2020-01-17 LGNDZ Narrow Range Bar Range Contraction
2020-01-17 MTLHY Crossed Above 200 DMA Bullish
2020-01-17 MTLHY Bollinger Band Squeeze Range Contraction
2020-01-17 MTLHY Narrow Range Bar Range Contraction
2020-01-17 NPHC Narrow Range Bar Range Contraction
2020-01-17 NPHC 50 DMA Support Bullish
2020-01-17 PBIO Bullish Engulfing Bullish
2020-01-17 PBIO Volume Surge Other
2020-01-17 PBIO 20 DMA Resistance Bearish
2020-01-17 PBIO Pocket Pivot Bullish Swing Setup
2020-01-17 PPCB Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2020-01-17 PPCB Volume Surge Other
2020-01-17 RCPIQ Narrow Range Bar Range Contraction
2020-01-17 RCPIQ Fell Below 20 DMA Bearish
2020-01-17 RCPIQ Fell Below 200 DMA Bearish
2020-01-17 RCPIQ Non-ADX 1,2,3,4 Bearish Bearish Swing Setup
2020-01-17 RCPIQ Bollinger Band Squeeze Range Contraction
2020-01-17 SGIOF Pocket Pivot Bullish Swing Setup
2020-01-17 SGIOF Narrow Range Bar Range Contraction
2020-01-17 SGIOF Volume Surge Other
2020-01-17 SGIOY MACD Bullish Signal Line Cross Bullish
2020-01-17 SGIOY Gilligan's Island Sell Setup Bearish Swing Setup
2020-01-17 SGIOY Stochastic Reached Overbought Strength
2020-01-17 SOAN Calm After Storm Range Contraction
2020-01-17 VBIZF Narrow Range Bar Range Contraction
2020-01-17 VGLS Bollinger Band Squeeze Range Contraction
2020-01-17 VGLS Spinning Top Other

In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which new candidate medications are discovered. Historically, drugs were discovered through identifying the active ingredient from traditional remedies or by serendipitous discovery. Later chemical libraries of synthetic small molecules, natural products or extracts were screened in intact cells or whole organisms to identify substances that have a desirable therapeutic effect in a process known as
classical pharmacology. Since sequencing of the human genome which allowed rapid cloning and synthesis of large quantities of purified proteins, it has become common practice to use high throughput screening of large compounds libraries against isolated biological targets which are hypothesized to be disease modifying in a process known as reverse pharmacology. Hits from these screens are then tested in cells and then in animals for efficacy.
Modern drug discovery involves the identification of screening hits, medicinal chemistry and optimization of those hits to increase the affinity, selectivity (to reduce the potential of side effects), efficacy/potency, metabolic stability (to increase the half-life), and oral bioavailability. Once a compound that fulfills all of these requirements has been identified, it will begin the process of drug development prior to clinical trials. One or more of these steps may, but not necessarily, involve computer-aided drug design. Modern drug discovery is thus usually a capital-intensive process that involves large investments by pharmaceutical industry corporations as well as national governments (who provide grants and loan guarantees). Despite advances in technology and understanding of biological systems, drug discovery is still a lengthy, "expensive, difficult, and inefficient process" with low rate of new therapeutic discovery. In 2010, the research and development cost of each new molecular entity was about US$1.8 billion. Drug discovery is done by pharmaceutical companies, with research assistance from universities. The "final product" of drug discovery is a patent on the potential drug. The drug requires very expensive Phase I, II and III clinical trials, and most of them fail. Small companies have a critical role, often then selling the rights to larger companies that have the resources to run the clinical trials.
Discovering drugs that may be a commercial success, or a public health success, involves a complex interaction between investors, industry, academia, patent laws, regulatory exclusivity, marketing and the need to balance secrecy with communication. Meanwhile, for disorders whose rarity means that no large commercial success or public health effect can be expected, the orphan drug funding process ensures that people who experience those disorders can have some hope of pharmacotherapeutic advances.

More about Drug Discovery